Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00194272 · ClinicalTrials.gov registry record · Phase 3
Two-Dose Methotrexate for Ectopic Pregnancy
A Phase 3 study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- Phase 3
- Development phase
- 100
- Enrollment target
NCT00194272: Completed Phase 3 study, sponsored by University of Pennsylvania.
NCT00194272 is a Phase 3 study that has completed, run by University of Pennsylvania. The registered enrollment target is 100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00194272, a Phase 3 study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 100 participants
- Enrollment target
Study Summary
This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
Interventions
- DRUG Methotrexate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2001-03 |
| Est. Completion | 2007-06 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00194272
The ClinicalTrials.gov registry entry for NCT00194272 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methotrexate is the first listed.
NCT00194272 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00194272 about?
NCT00194272 is a clinical study titled "Two-Dose Methotrexate for Ectopic Pregnancy". This study examines the safety and acceptability of a novel "two dose" regimen of methotrexate to treat ectopic pregnancy.
What is the current status of trial NCT00194272?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 100 participants. The study started on 2001-03. Estimated completion is 2007-06.
What interventions are being tested in trial NCT00194272?
The interventions under investigation include: Methotrexate (DRUG).
Who is sponsoring clinical trial NCT00194272?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.